Predictors for severe cardiac complications after hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 33, Issue 10, 2004, Pages 1043-1047

  Sakata Yanagimoto, M ^a   Kanda, Y ^a   Nakagawa, M ^a   Asano Mori, Y ^a   Kandabashi, K ^a   Izutsu, K ^a   Imai, Y ^a   Hangaishi, A ^a   Kurokawa, M ^a   Tsujino, S ^a   Ogawa, S ^a   Chiba, S ^a   Motokura, T ^a   Hirai, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anthracycline; Cardiac toxicity; Ejection fraction; Stem cell transplantation

Indexed keywords

ANTHRACYCLINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; MELPHALAN;

ADULT; ARTICLE; BODY TEMPERATURE; CARDIOGENIC SHOCK; CARDIOTOXICITY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FATALITY; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; TACHYCARDIA; WHOLE BODY RADIATION;

ADULT; ANTHRACYCLINES; BODY TEMPERATURE; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 2942613848     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704487     Document Type: Article

References (15)

1. Akahori M, Nakamae H, Hino M et al. Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue. Bone Marrow Transplant 2003; 31: 585-590.
2. Bearman SI, Petersen FB, Schor RA et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 1990; 5: 173-177.
3. Braverman AC, Antin JH, Plappert MT et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 1991; 9: 1215-1223.
4. Brockstein BE, Smiley C, Al-Sadir J et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885-894.
5. Fujimaki K, Maruta A, Yoshida M et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001; 27: 307-310.
6. Goldberg MA, Antin JH, Guinan EC et al. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 1986; 68: 1114-1118.
7. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001; 28: 283-287.
8. Nakamae H, Tsumura K, Hino M et al. QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide. Lancet 2000; 355: 805-806.
9. Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12: 998-1004.
10. Herait P, Poutignat N, Marty M et al. Early assessment of a new anticancer drug analogue - are the historical comparisons obsolete? The French experience with pirarubicin. Eur J Cancer 1992; 28A: 1670-1676.
11. Casazza AM, Savi G, Pratesi G et al. Antitumor activity in mice of 4′-deoxydoxorubicin in comparison with doxorubicin. Eur J Cancer Clin Oncol 1983; 19: 411-418.
12. Hori S, Shirai M, Hirano S et al. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity. Gann 1977; 68: 685-690.
13. Anderlini P, Benjamin RS, Wong FC et al. Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia. J Clin Oncol 1995; 13: 2827-2834.
14. Zangari M, Henzlova MJ, Ahmad S et al. Predictive value of left ventricular ejection fraction in stem cell transplantation. Bone Marrow Transplant 1999; 23: 917-920.
15. Kakavas PW, Ghalie R, Parrillo JE et al. Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function. Bone Marrow Transplant 1995; 15: 859-861.